Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

Instant vertebral assessment (IVA) in combination with bone densitometry (BDM): A new standard in the diagnosis of osteoporosis?

Pieter Jager, Annemiek Stiekema, Sharon Jonkman, Wendy Koolhaas, Bruce Wolffenbuttel, Riemer Slart, Collin Webber and Karen Gulenchyn
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 127P;
Pieter Jager
1Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemiek Stiekema
1Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Jonkman
1Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Koolhaas
1Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Wolffenbuttel
2Endocrinology, University Medical Center Groningen, Groningen, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riemer Slart
1Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Collin Webber
3Nuclear Medicine, Hamilton Health Services, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Gulenchyn
3Nuclear Medicine, Hamilton Health Services, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

432

Objectives: Prevalent vertebral fractures constitute a significant risk factor for future fractures, which is independent of the bone density. New developments in DEXA machines allow visual and software-based detection of vertebral fractures. We aimed to determine the added value of IVA performed immediately after BDM. Methods: All patients referred to our university medical center department for BDM also underwent IVA om a Hologic Discovery A bone densitometer. Studies were analyzed by 3 experienced operators and physicians. The frequency of vertebral fractures was determined in the the entire cohort and in various subgroups. Referring physicians were asked for their opinion on the added value of IVA using a short questionaire. Results: 958 patients were included (64% females, 52% postmenopausal), 29% were assessed because of primary osteoporosis, 71% for secondary osteoporosis. 30% used corticosteroids. In 2% IVA was not possible due to extreme adipositas or deformities. In 71% T4 and in 86% T5 was the upper vertebral level that could be assessed. The main finding in this cohort was a prevalence of vertebral fractures of 26%. In 68% of these patients this fracture was unknown. We found a mean of 1.8 vertebral fractures per patient. Even after excluding mild fractures (=20-25% heightloss) still 17% of the patients had moderate (>25%) or severe (>40% heightloss) vertebral fractures. In the 27% with normal bone density the vertebral fracture prevalence was still 18%, in the 43% with ostopenia 23%, and in the 29% with osteoporisis 36%. In primary osteoporosis the vertebral fracture prevalence was 45%, in secondary osteoporosis 33%. Referring physicians reported that in 58% IVA results increased their understanding, and in 27% had an impact on treatment. Conclusions: IVA added to BMD is a very convenient and patient friendly diagnostic tool with a high diagnostic yield as the method detected vertebral fractures in 1 out of 4 patients. In 2/3 of these cases these fractures were unknown. In 18% of patients with normal bone density vertebral fractures were detected.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Instant vertebral assessment (IVA) in combination with bone densitometry (BDM): A new standard in the diagnosis of osteoporosis?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Instant vertebral assessment (IVA) in combination with bone densitometry (BDM): A new standard in the diagnosis of osteoporosis?
Pieter Jager, Annemiek Stiekema, Sharon Jonkman, Wendy Koolhaas, Bruce Wolffenbuttel, Riemer Slart, Collin Webber, Karen Gulenchyn
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 127P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Instant vertebral assessment (IVA) in combination with bone densitometry (BDM): A new standard in the diagnosis of osteoporosis?
Pieter Jager, Annemiek Stiekema, Sharon Jonkman, Wendy Koolhaas, Bruce Wolffenbuttel, Riemer Slart, Collin Webber, Karen Gulenchyn
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 127P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
Show more General Clinical Specialties: Endocrinology

Clinical Studies in Endocrinology

  • FDOPA-PET in neuroendocrine tumors: An open question?
  • Preoperative I-123/Tc-99m sestamibi subtraction SPECT/CT in primary hyperparathyroidism
  • I-123-Iodometomidate for adrenal imaging — First clinical experience
Show more Clinical Studies in Endocrinology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire